BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
SNCA
,
Coagulation
,
HIV infection
,
Leukocyte
,
Anticancer prodrugs
,
Prozac
,
rs2300478
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Ion transport domain
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Pons
Prefrontal cortex
Cingulate cortex
Caudate nucleus
Fetal brain
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Vesicular stomatitis Indiana virus disease
Toxoplasmosis
Nerve injury
Perforation of tympanic membrane
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
CGP 60474
OTS-167
A 443654
flavopiridol
Glesatinib
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
TDP2
PPP2R2C
NCL
NR5A1
CRKL
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Adipocyte ASC cells treated with small molecule perturbagens
L1000 CMAP - Colorectal cancer HT29.311 cells with CRISPR-targeted gene knockouts
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Ion transport domain
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effects of Sildenafil on CFTR-dependent Ion Transport Activity
Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis
Study of Ivacaftor in Cystic Fibrosis Subjects Aged 6 to 11 Years With the G551D Mutation
Safety Study of Ivacaftor in Subjects With Cystic Fibrosis
Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older With the G551D Mutation
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ